[go: up one dir, main page]

FR2951085B1 - Utilisation de composes phenoliques pour la deglycation des proteines - Google Patents

Utilisation de composes phenoliques pour la deglycation des proteines

Info

Publication number
FR2951085B1
FR2951085B1 FR0904838A FR0904838A FR2951085B1 FR 2951085 B1 FR2951085 B1 FR 2951085B1 FR 0904838 A FR0904838 A FR 0904838A FR 0904838 A FR0904838 A FR 0904838A FR 2951085 B1 FR2951085 B1 FR 2951085B1
Authority
FR
France
Prior art keywords
deglycation
proteins
phenolic compounds
phenolic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0904838A
Other languages
English (en)
Other versions
FR2951085A1 (fr
Inventor
Daniel Jean
Maryse Pouligon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST SUBSTANCES VEGETALES
Original Assignee
INST SUBSTANCES VEGETALES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST SUBSTANCES VEGETALES filed Critical INST SUBSTANCES VEGETALES
Priority to FR0904838A priority Critical patent/FR2951085B1/fr
Priority to PCT/IB2010/054561 priority patent/WO2011042890A2/fr
Publication of FR2951085A1 publication Critical patent/FR2951085A1/fr
Application granted granted Critical
Publication of FR2951085B1 publication Critical patent/FR2951085B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR0904838A 2009-10-09 2009-10-09 Utilisation de composes phenoliques pour la deglycation des proteines Active FR2951085B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0904838A FR2951085B1 (fr) 2009-10-09 2009-10-09 Utilisation de composes phenoliques pour la deglycation des proteines
PCT/IB2010/054561 WO2011042890A2 (fr) 2009-10-09 2010-10-08 Utilisation de composés phénoliques pour la déglycation des protéines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0904838A FR2951085B1 (fr) 2009-10-09 2009-10-09 Utilisation de composes phenoliques pour la deglycation des proteines

Publications (2)

Publication Number Publication Date
FR2951085A1 FR2951085A1 (fr) 2011-04-15
FR2951085B1 true FR2951085B1 (fr) 2012-05-18

Family

ID=41667544

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0904838A Active FR2951085B1 (fr) 2009-10-09 2009-10-09 Utilisation de composes phenoliques pour la deglycation des proteines

Country Status (2)

Country Link
FR (1) FR2951085B1 (fr)
WO (1) WO2011042890A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014048888A1 (fr) * 2012-09-28 2014-04-03 Nestec S.A. Acide dihydroférulique et/ou acide dihydrocaféique destinés à être utilisés dans le traitement de maladies métaboliques
CN107540646B (zh) * 2017-08-29 2020-12-01 连云港恒运药业有限公司 维拉佐酮中间体合成方法
FR3105923B1 (fr) * 2020-01-07 2022-10-21 Centre Nat Rech Scient Utilisation de la taxodione comme agent anti-glycation
JP2025531314A (ja) 2022-09-23 2025-09-19 エーツーピー サイエンシズ ヒト又は動物における老化関連障害の予防及び／又は治療に使用されるサゲリン酸及びサゲリン酸を含有する組成物
CN119504613A (zh) * 2024-09-29 2025-02-25 江苏海洋大学 含喹唑啉单元的新型香豆素衍生物及其制备方法与应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1327887A3 (fr) 1995-01-18 2008-12-10 Synvista Therapeutics, Inc. Utilisation de composés de thiazolium pour empêcher et inverser la formation de produits finis de glycosylation avancée
WO1999037149A1 (fr) * 1998-01-27 1999-07-29 Brigham & Women's Hospital Procede de traitement des lesions cytotoxiques
WO2000015215A1 (fr) * 1998-09-15 2000-03-23 Korea Research Institute Of Bioscience And Biotechnology Composition contenant des derives d'acide cinnamique pour prevenir ou traiter les infections liees a un niveau eleve de lipides dans le sang
JP2000256259A (ja) * 1999-03-11 2000-09-19 Nippon Zoki Pharmaceut Co Ltd メイラード反応阻害剤
US6787566B2 (en) 1999-04-05 2004-09-07 City Of Hope Breakers of advanced glycation endproducts
FR2810548A1 (fr) 2000-06-26 2001-12-28 Oreal Utilisation d'ergothioneine et/ou de ses derives comme agent anti-glycation
FR2829760B1 (fr) 2001-09-17 2004-03-26 Oreal Procede de preparation d'acides alpha-(phenyl)cinnamique et/ou de leurs derives, et leur utilisation dans une composition cosmetique
US20040202731A1 (en) * 2003-04-08 2004-10-14 Gow Robert T. Rosmarinic acid composition
EP1481669A1 (fr) * 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. Utilisation des polyhydroxy phenols et des polyphenols pour la modulation de l'activité de p-selectin
CN101095668B (zh) * 2006-06-29 2010-09-08 山东绿叶天然药物研究开发有限公司 迷迭香酸在制备治疗或预防肝纤维化和肾纤维化的药物中的应用
WO2008020031A1 (fr) * 2006-08-16 2008-02-21 Action Medicines, S.L. Utilisation de dérivés de 2,5-dihydroxybenzène pour le traitement de maladies angiogéniques
WO2008073684A1 (fr) * 2006-12-08 2008-06-19 Lipo Chemicals Inc. Composition pour traiter le vieillissement de la peau comprenant un acide hydroxycinnamique tel que l'acide p-coumarique
WO2008112368A2 (fr) * 2007-02-08 2008-09-18 Emisphere Technologies, Inc. Agents de distribution d'acide phénylalkylcarboxylique
FR2918570B1 (fr) * 2007-07-09 2012-10-05 Engelhard Lyon DIGLYCATION DES AGEs.
BRPI0802688C1 (pt) * 2008-06-25 2021-05-25 Acef S/A processo de obtenção de extrato rico em ácido rosmarínico (ar) obtido da espécie vegetal origanum vulgare e uso do extrato obtido

Also Published As

Publication number Publication date
WO2011042890A2 (fr) 2011-04-14
FR2951085A1 (fr) 2011-04-15
WO2011042890A3 (fr) 2011-06-03

Similar Documents

Publication Publication Date Title
EP2486876A4 (fr) Ciseaux pour endoscope
EP2467473A4 (fr) Polypeptides de kétoréductase pour la préparation de phényléphrine
CR20130266A (es) PROTEÍNAS DE UNIÓN AL TNF-a
FR2945621B1 (fr) Structure de couplage pour gyrometre resonnant
EP2488122A4 (fr) Vis poreuse pour os
EP2542878A4 (fr) Récipient flexible pour échantillon
EP2475309A4 (fr) Patch pour hernie
EP2245927A4 (fr) Aérosol pour désinsectisation
PT2406399T (pt) Proteínas mirac
EP2542696A4 (fr) Biomarqueurs pour théranostique
EP2459300A4 (fr) Liquides ioniques
EP2510828A4 (fr) Récipient pour cosmétiques
EP2491089A4 (fr) Materiau de frottement pour freins friction
FR2954857B3 (fr) Accumulateur ion-lithium specifique pour l'allumage de motos
EP2634634A4 (fr) Résine de liant pour toners
EP2556094A4 (fr) Polymères pour la séparation des métaux
EP2762488A4 (fr) Peptide pour la synthèse de la silice, et son utilisation
EP2500038A4 (fr) Composition phatmaceutique pour usage externe/
BRPI1008533A2 (pt) separador de líquidos
EP2438713A4 (fr) Détermination d'utilisation de serveur
FR2959055B1 (fr) Perfectionnement pour harmonica
FR2946505B1 (fr) Chaussure pour ski
FR2968538B1 (fr) Prothese pour membre inferieur
EP2639279A4 (fr) Composition pour vulcaniser l'adhérence
FR2941591B1 (fr) Utilisation de la chitine pour la biofertilisation des cultures non-legumineuses

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17